午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Pay attention! How should the big hospital outpatient medical treatment enterprise should respond?
 
Author:中國銘鉉 企劃部  Release Time:2017-7-20 10:14:47  Number Browse:584
 
With the promotion of medical reform on July 20, the number of outpatient visits in large hospitals has changed dramatically, not falling, but falling dramatically. 
 
Recently, who Beijing development planning commission held a pharmaceutical analysis, comprehensive reform situation separately introduced at the meeting, the Beijing medicine separate comprehensive reform implementation for nearly three months, expenses for medicine and medicine proportion, two tertiary hospitals ZhenLiaoLiang, large equipment inspection fee, medicare patients burden in the "five down" trend. 
 
▍ affect drug firms three "drop" 
 
According to the report, compared with the same period last year, the number of emergency medical services in Beijing's third-grade hospitals decreased by 12.9% compared with the same period last year, while the secondary hospitals decreased by 5.2%. According to the statistics, the number of patients in the city of Beijing is 550 million in 2016, and if the rate of decline is at that rate, the number of visits to the hospital in Beijing will be reduced this year. 
 
In terms of drug purchase, since April 8, just three months, the drug sunshine purchase amount accumulative total of Beijing reached 14.1 billion yuan, save drug cost 1.14 billion yuan, drug prices fell more than 8.1% on average. 
 
The impact of these three "health" factors on drug companies is self-evident in the dramatic decline in the number of hospital outpatients, the decrease in the proportion of drugs and the decline of drug prices. 
 
What's more, it is not just Beijing, which is facing big changes across the country, especially in 11 pilot provinces and 200 pilot cities. 
 
▍ nationwide drug prices, fall MenZhenLiang reduction 
 
In April, the national health and family planning commission issued a notice on the comprehensive reform of public hospitals. According to the requirements, all public hospitals in China will have to cancel the drug addition before September 30 this year. Many provinces have already dropped the drug addition, accelerated grading and treatment. 
 
On July 15, 770 public hospitals in guangdong province, the province of medicine, announced a total elimination of all drugs. In recently issued by the guangzhou public hospital comprehensive reform implementation plan ", it explicitly requested by the end of 2017, to make an appointment referral accounts for the proportion of public hospital outpatient medical consultations to 20% above, level 3 general hospital outpatient clinic visits decline. 
 
On July 18, issued by the general office of the guangdong people's government of guangdong province to promote medical association construction and development of the implementation plan ", clear level medical institutions to gradually reduce the proportion of common disease, frequently-occurring disease, in a stable condition with a chronic illness, basic health care and rehabilitation, nursing and other agencies to clear diagnosis, patients in stable condition to provide treatment, rehabilitation, nursing and other services. All three tertiary public hospitals in the province will start the medical joint construction work before the end of October 2017. 
 
Graded diagnosis and treatment is the first of the basic medical system of Chinese characteristics, the important measures of medical reform. Reducing the number of hospital outpatients, reducing the proportion of drugs and lowering the price of drugs are the main requirements of the reform. 
 
▍ drug firms how to deal with? 
 
In the advance of the hierarchical diagnosis and treatment policies, we should see the decrease in the number of outpatient visits in large hospitals, and the increase in the number of medical outpatients. 
 
According to the report, the number of primary hospitals and primary medical institutions in Beijing increased by 8.6 percent, and some community health service organizations in urban areas increased their medical treatment by about 20 percent. 
 
The base market is large and fragmented, slow growth, and it is difficult to market well and will not generate profits in a short period of time. It is also an important reason why many pharmaceutical companies have focused on the market of large hospitals with high concentration. 
 
At the same time, the medical association binds large hospitals and grass-roots communities, and patients who seek medical treatment in large hospitals will return to the base. As a result, the focus of the pharmaceutical industry must be extended from big hospitals to grassroots communities, and if you focus on big hospitals instead of working in the grass-roots community, your entire sales chain will be broken. 
 
In the future, the primary-level market will become the new export of drug enterprise's performance, and the only export. It can be said that the products of the pharmaceutical companies are the advantages of postoperative rehabilitation and slow disease treatment. For the primary market, who will first lay who will occupy the dominant position. 
 
Previous article:Two drugs are involved in bribes, be wanted by the whole city, check the doctor's office!
Next article:The second batch of drug negotiations released a quick look at the health care payment standards
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號